Clopidogrel placebo

DRUG3 trials

Sponsors

Boehringer Ingelheim, Eli Lilly and Company, Sanofi

Conditions

Acute Coronary SyndromeCoronary ArteriosclerosisStroke

Phase 2

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event

CompletedNCT00356135

Eli Lilly and CompanyAcute Coronary Syndrome, Coronary Arteriosclerosis

Start: 2006-07-31End: 2008-12-31Updated: 2010-11-03

Phase 4

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

CompletedNCT00153062

Boehringer IngelheimStroke

Start: 2003-08-31Updated: 2014-05-13

COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke

CompletedNCT00814268

Start: 2008-12-31End: 2012-05-31Updated: 2014-02-28

Related Papers

Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke

Stroke2016-07-1561 citations

Abstract T P334: Clopidogrel and Aspirin versus Aspirin Alone for Prevention of Recurrent Ischemic Lesion in Acute Atherothrombotic Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial

Stroke2014-02-015 citations

Low Glomerular Filtration Rate, Recurrent Stroke Risk, and Effect of Renin–Angiotensin System Modulation

Stroke2013-08-3032 citations

Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.

2012-06-2661 citations

Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.

2012-01-1914 citations

Level of systolic blood pressure within the normal range and risk of recurrent stroke.

2011-11-01161 citations

Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study.

2010-09-01123 citations

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

2008-08-29219 citations

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.

2008-08-27573 citations

Telmisartan to prevent recurrent stroke and cardiovascular events.

2008-08-27502 citations